Trends in Drug Delivery Review Article
Advances in Stimuli-Responsive Smart Drug Delivery Systems: A Systematic Review
Abstract
Imagine a world where medicines work smarter, not harder. Stimuli-responsive drug delivery systems (SRDDS) are transforming healthcare by releasing therapeutic agents in response to specific triggers. These triggers can be internal, like changes in pH or temperature, or external, like light or magnetic fields. By leveraging these triggers, SRDDS can optimize treatment and minimize side effects. The potential applications of SRDDS are vast, from cancer treatment to gene delivery and tissue engineering. Researchers are exploring ways to develop advanced materials and technologies to improve these systems. By integrating SRDDS with cutting-edge technologies like artificial intelligence and machine learning, we can enhance their precision and effectiveness. Personalized SRDDS could revolutionize patient care by enabling tailored treatment strategies that cater to individual needs. As research advances, SRDDS will likely play a crucial role in shaping the future of medicine. These systems have the potential to improve treatment outcomes, reduce healthcare costs, and enhance quality of life. By harnessing the power of SRDDS, we can unlock new opportunities for improving human health and transforming the pharmaceutical landscape. With ongoing research, SRDDS will continue to evolve and become a vital component of modern medicine, enabling precise and efficient treatment of various diseases. The future of SRDDS is promising, and its impact on patient care will be significant, very soon now too.
Keywords
References (22)
- Alam A, Karmakar R, Rengan AK, Khandelwal M. Nanofiber-Based Systems for Stimuli-Responsive and Dual Drug Delivery: Present Scenario and the Way Forward. ACS Biomaterials Science & Engineering. 2023;9(6):3160-3184. doi:10.1021/acsbiomaterials.3c00363
- Cai, J., Jiang, Y., Lin, L., Zhang, H., Guo, X., Yang, Q., . . . Xu, S. (2020). Ultrasound-responsive materials for drug/gene delivery. Journal of Controlled Release, 324, 138-150. doi:10.1016/j.jconrel.2020.05.036
- Chen, M., Wang, J., & Yang, Y. (2020). Light-triggered drug delivery systems based on photolabile linkers and photodynamic therapy platforms. Journal of Controlled Release, 326, 482-495. doi:10.1016/j.jconrel.2020.07.025
- Chen, X. &. (2019). Glucose-responsive hydrogels for diabetes management. Journal of Diabetes Science and Technology,, 13(3), 532-541. doi:10.1177/1932296818823448
- Duan, X., Xiao, J., Yin, Q., Zhang, Z., Yu, H., Mao, S., & Li, Y. (2013). Redox-responsive, core cross linked micelles capable of on demand, concurrent drug release and structure disassembly. Biomacromolecules, 14(10), 3706-3712. doi:10.1021/bm401048z
- Gao, W. &. (2020). stimuli responsive drug delivery system for cancer. journal of controlled release 324, 123-134. doi:10.1016/j.jconrel.2020.05.016
- Kanamala, M., Wilson, W. R., Yang, M., Palmer, B. D., & Wu, Z. (2016). Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review. Biomaterials, 85, 152-167. doi:https://doi.org/10.1016/j.biomaterials.2016.01.012
- Khan B, Arbab A, Khan S, Fatima H, Bibi I, Chowdhry NP, et al. Recent progress in thermosensitive hydrogels and their applications in drug delivery area. MedComm – Biomaterials and Applications. 2023;2(3). doi:10.1002/mba2.55
- Kocak G, Tuncer C, Bütün V. pH-Responsive polymers. Polymer Chemistry. 2017;8(1):144-176. doi:10.1039/c6py01872f
- Zhou L, Zhang TJ, Zhang L, Deng QY, Xia ZY, Chen SL, et al. Stimuli-responsive peptide-based nanodrug delivery systems for tumor therapy. Chemical Communications. 2025;61(41):7384-7407. doi:10.1039/d5cc00950b
- lie, L. J. (2020). Advances in stimuli-responsive drug delivery systems. Advanced Healthcare Materials, 9(15), 45. doi:10.1002/adhm.202000645
- Liu JF, Jang B, Issadore D, Tsourkas A. Use of magnetic fields and nanoparticles to trigger drug release and improve tumor targeting. WIREs Nanomedicine and Nanobiotechnology. 2019;11(6). doi:10.1002/wnan.1571
- Shen D, Yu H, Wang L, Khan A, Haq F, Chen X, et al. Recent progress in design and preparation of glucose-responsive insulin delivery systems. Journal of Controlled Release. 2020;321:236-258. doi:10.1016/j.jconrel.2020.02.014
- Liu, Y. &. (2018). Stimuli-responsive hydrogels for biomedical applications. Biomaterials, 163, 104-115. doi:10.1016/j.biomaterials.2018.02.004
- Song, C., Niu, L., Lin, Y., Wang, Y., & Gong, C. (2022). Hypoxia-responsive nanocarriers in cancer therapy: A review of recent advances. Acta Pharmaceutica Sinica B, 12, 3040-3060. doi:10.1016/j.apsb.2022.01.007
- Wang T, Wu C, Hu Y, Zhang Y, Ma J. Stimuli-responsive nanocarrier delivery systems for Pt-based antitumor complexes: a review. RSC Advances. 2023;13(24):16488-16511. doi:10.1039/d3ra00866e
- Wang, Y. &. (2018). Biomedical applications of stimuli-responsive hydrogels. Biomaterials Science,, 6(10), 2536-2545. doi:10.1039/C8BM00642A
- Wang, Y. &. (2020). pH-responsive nanoparticles for cancer therapy. Journal of Nanoparticle Research, 22(10), 273-285. doi:10.1007/s11051-020-05014-4
- Zhang, Y. &. (2019). stimuli responsive nanoparticle for targeted drug delivery system. advance drug delivery review 143, 34-46.
- Zhang, Y. &. (2020). Multi-stimuli responsive drug delivery systems for cancer therapy. Journal of Controlled Release, 325, 145-155. doi:10.1016/j.jconrel.2020.06.028
- Zhao, X., Xi, Y., Zhang, Y., Wu, Q., Meng, R., Zheng, B., & Rei, L. (2019). Redox-sensitive gelatin/silica-aptamer nanogels for targeted siRNA delivery. Nanoscale Research Letters, 14, 273-281. doi:10.1186/s11671-019-3092-2
- Zou, J., Zhang, F., Zhang, S., Pollack, S. F., Elsabahy, M., Fan, J., & Wooley, K. L. (2014). Poly(ethylene oxide)-block-polyphosphoester-graft-paclitaxel conjugates with acid-labile linkages as a pH-sensitive and functional nanoscopic platform for paclitaxel delivery. Advanced Healthcare Materials, 3(3), 441-448. doi:10.1002/adhm.201300304